SCHEMBL2256014

SCHEMBL2256014

COc1cccc2cc3ccc[c]c3cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
NQO1 P15559 1/20 0.43
PDGFRB P09619 2/20 0.36
EGFR P00533 1/20 0.36
KDR P35968 1/20 0.36
NQO2 P16083 1/20 0.35
ACHE P22303 6/20 0.35
BCHE P06276 4/20 0.35
FLT3 P36888 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
PDGFRA P16234 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2253192 0.93 NQO1 (0.47) KDM4EALDH1A1HPGDHSD17B10NQO1
SCHEMBL2256151 0.83 TLR8 (0.38) KDM4EALDH1A1CA12CA1CA2
SCHEMBL2386165 0.80 PDGFRB (0.43) KDM4EALDH1A1HPGDNQO1PDGFRB
SCHEMBL8391116 0.80 ALDH1A1 (0.59) KDM4EALDH1A1HPGDHSD17B10NQO1
SCHEMBL29862025 0.80 ALDH1A1 (0.59) KDM4EALDH1A1HPGDHSD17B10NQO1
SCHEMBL2252094 0.79 MCHR1 (0.45)
SCHEMBL2701955 0.79 CYP1A2 (0.52) ALDH1A1HPGDHSD17B10
SCHEMBL29919905 0.78 NQO1 (0.67) KDM4EALDH1A1HPGDHSD17B10NQO1
SCHEMBL8393507 0.78 NQO1 (0.67) KDM4EALDH1A1HPGDHSD17B10NQO1
SCHEMBL383902 0.77 CA1 (0.41) KDM4EALDH1A1HPGDHSD17B10NQO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1916244-B1 THIOPHENE COMPOUND HAVING SULFONYL GROUP AND PROCESS FOR PRODUCING THE SAME NISSAN CHEMICAL IND LTD (JP) 2013-12-04 EP disclosed
EP-1882694-B1 OLIGOMERS AND POLYMERS OF THIOPHENE COMPOUNDS HAVING PHOSPHORIC ESTER AND PROCESS FOR PRODUCING THE SAME NISSAN CHEMICAL IND LTD (JP) 2013-04-03 EP disclosed
US-8008425-B2 Thiophene compound having sulfonyl group and process for producing the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-08-30 US disclosed
US-20090127491-A1 THIOPHENE COMPOUND HAVING SULFONYL GROUP AND PROCESS FOR PRODUCING THE SAME NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-05-21 US disclosed
EP-1916244-A1 THIOPHENE COMPOUND HAVING SULFONYL GROUP AND PROCESS FOR PRODUCING THE SAME Nissan Chemical Industries, Ltd. (JP) 2008-04-30 EP disclosed
US-20060293503-A1 Polyaminopyridines and method for producing same SUMITOMO SEIKA CHEMICALS CO., LTD (JP) 2006-12-28 US disclosed
EP-1669390-A1 POLYAMINOPYRIDINES AND METHOD FOR PRODUCING SAME SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2006-06-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090127491-A1 THIOPHENE COMPOUND HAVING SULFONYL GROUP AND PROCESS FOR PRODUCING THE SAME TST, ABCG2, CBR3 KDM4E 2440/4885ALDH1A1 1104/4885HPGD 2516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.